Evidence map›Paper›PMID 19693633›Full record

ArticleJournal of general internal medicine2009

Systematic review of pharmacogenetic warfarin dosing.

Rianne M F van Schie, Andrea L Jorgensen, Anthonius de Boer, Anke-Hilse Maitland-van der Zee, EU-PACT study group

3 registry-linked trialsAbstract readCommentLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of general internal medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01119261 phase4completednot on this mapstarted 2010, after this paper: background citation

EUropean Pharmacogenetics of AntiCoagulant Therapy - Acenocoumarol

TypeinterventionalSponsorUtrecht Institute for Pharmaceutical SciencesRan2010 to 2013Enrolled970ConditionsVenous Thromboembolism, Atrial FibrillationArmsGenotype-guided dosing algorithm, Non-genotype-guided dosing algorithm
NCT01119274 phase4completednot on this mapstarted 2010, after this paper: background citation

EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon

TypeinterventionalSponsorUtrecht Institute for Pharmaceutical SciencesRan2010 to 2013Enrolled970ConditionsVenous Thromboembolism (VTE), Atrial Fibrillation (AF)ArmsGenotype-guided dosing algorithm, Non-genotype-guided dosing algorithm
NCT01119300 phase4completednot on this mapstarted 2011, after this paper: background citation

EUropean Pharmacogenetics of AntiCoagulant Therapy - Warfarin

TypeinterventionalSponsorUtrecht Institute for Pharmaceutical SciencesRan2011 to 2013Enrolled455ConditionsVenous Thromboembolism, Atrial FibrillationArmsGenotype-guided dosing algorithm, Standard care
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Rianne M F van Schie
Andrea L Jorgensen
Anthonius de Boer
Anke-Hilse Maitland-van der Zee
EU-PACT study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PharmacogeneticsReview Literature as TopicClinical Trials as TopicHumansWarfarinWarfarin

Identifiers

PMID19693633
PMCPMC2762507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.